Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Tempus AI Inc. (TEM) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Health Information Services
$70.11
-1.89 (-2.63%)Did TEM Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Tempus is one of their latest high-conviction picks.
Based on our analysis of 12 Wall Street analysts, TEM has a neutral consensus with a median price target of $65.00 (ranging from $55.00 to $70.00). The overall analyst rating is Buy (7.7/10). Currently trading at $70.11, the median forecast implies a -7.3% downside. This outlook is supported by 6 Buy, 6 Hold, and 0 Sell ratings.
The most optimistic forecast comes from David Westenberg at Piper Sandler, projecting a 0.2% downside. Conversely, the most conservative target is provided by David Westenberg at Piper Sandler, suggesting a 21.6% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for TEM.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
May 20, 2025 | B of A Securities | Michael Ryskin | Neutral | Maintains | $68.00 |
May 15, 2025 | Piper Sandler | David Westenberg | Neutral | Maintains | $70.00 |
May 9, 2025 | Morgan Stanley | Tejas Savant | Overweight | Maintains | $65.00 |
May 7, 2025 | Needham | Ryan MacDonald | Buy | Reiterates | $70.00 |
Apr 24, 2025 | Needham | Ryan MacDonald | Buy | Reiterates | $70.00 |
Apr 21, 2025 | BTIG | Mark Massaro | Buy | Initiates | $60.00 |
Apr 10, 2025 | Needham | Ryan MacDonald | Buy | Reiterates | $70.00 |
Mar 6, 2025 | Morgan Stanley | Tejas Savant | Overweight | Maintains | $60.00 |
Mar 4, 2025 | Piper Sandler | David Westenberg | Neutral | Maintains | $55.00 |
Mar 3, 2025 | B of A Securities | Michael Ryskin | Neutral | Maintains | $60.00 |
Feb 25, 2025 | Needham | Ryan MacDonald | Buy | Maintains | $70.00 |
Feb 25, 2025 | Guggenheim | Subbu Nambi | Buy | Reiterates | $0.00 |
Feb 25, 2025 | JP Morgan | Rachel Vatnsdal | Neutral | Downgrade | $55.00 |
Feb 12, 2025 | William Blair | Andrew Brackmann | Market Perform | Downgrade | $0.00 |
Feb 5, 2025 | TD Cowen | Dan Brennan | Buy | Reinstates | $74.00 |
Jan 14, 2025 | Needham | Ryan MacDonald | Buy | Reiterates | $56.00 |
Jan 14, 2025 | Loop Capital | Mark Schappel | Buy | Maintains | $52.00 |
Dec 13, 2024 | Wolfe Research | Outperform | Initiates | $0.00 | |
Dec 13, 2024 | B of A Securities | Neutral | Maintains | $0.00 | |
Dec 9, 2024 | Guggenheim | Subbu Nambi | Buy | Initiates | $74.00 |
The following stocks are similar to Tempus based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Tempus AI Inc. has a market capitalization of $12.35B with a P/E ratio of -11.3x. The company generates $803.32M in trailing twelve-month revenue with a -88.3% profit margin.
Revenue growth is +75.4% quarter-over-quarter, while maintaining an operating margin of -26.9% and return on equity of -1,324.7%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops AI solutions for various industries.
Tempus AI Inc. generates revenue by providing customized AI platforms that help enterprises enhance operational efficiency and decision-making. By integrating machine learning and predictive analytics, the company offers tools that streamline complex data into actionable insights, serving sectors like healthcare, finance, and logistics.
The company is recognized for its expertise in natural language processing and computer vision, which broadens its AI tool offerings. Tempus AI Inc. plays a crucial role in setting industry standards for AI deployment and is committed to advancing the digital transformation across multiple industries.
Healthcare
Health Information Services
2,400
Mr. Eric P. Lefkofsky J.D.
United States
2024
TEM expands major partnerships with AZN, ILMN, and PSNL, fueling AI-driven R&D and widening its precision medicine reach.
Tempus AI surges 12.5% on new AI tools, a $200M AstraZeneca deal, and clinical data expansion- but is it time to buy?
TEM investors can lead a securities fraud lawsuit against Tempus AI, Inc. with the Schall Law Firm, as announced in Los Angeles.
The opportunity for TEM investors to lead a securities fraud lawsuit suggests potential financial losses and legal risks, which could negatively impact Tempus AI's stock value and investor sentiment.
A class action lawsuit has been filed against Tempus AI, Inc. (NASDAQ: TEM) for securities purchased between August 6, 2024, and May 27, 2025. Investors can apply as lead plaintiffs until August 11, 2025.
The class action lawsuit against Tempus AI, Inc. may signify potential legal and financial risks, affecting stock performance and investor sentiment regarding the company's stability.
A class action was filed for investors who bought Tempus AI, Inc. (NASDAQ: TEM) stock between August 6, 2024, and May 27, 2025, related to its AI-enabled precision medicine claims.
The class action lawsuit against Tempus AI may indicate potential legal and financial risks, affecting stock performance and investor confidence in the company.
Rosen Law Firm is investigating potential securities claims against Tempus AI, Inc. (NASDAQ: TEM) for allegedly issuing misleading business information to investors.
Allegations of misleading information can lead to stock price volatility and legal repercussions for Tempus AI, impacting shareholder value and market perception.
A class action has been filed for investors of Tempus AI, Inc. (NASDAQ: TEM) who purchased shares between August 6, 2024, and May 27, 2025, related to its AI-enabled solutions.
The class action lawsuit against Tempus AI could indicate potential legal and financial risks, impacting stock value and investor sentiment. Legal outcomes may affect future operations and profitability.
Levi & Korsinsky has launched an investigation into Tempus AI, Inc. (NASDAQ:TEM) following a report from Spruce Point Capital Management highlighting potential federal securities law violations.
The investigation into Tempus AI for potential securities law violations raises red flags about its financial health, potentially impacting stock performance and investor confidence.
Based on our analysis of 12 Wall Street analysts, Tempus AI Inc. (TEM) has a median price target of $65.00. The highest price target is $70.00 and the lowest is $55.00.
According to current analyst ratings, TEM has 6 Buy ratings, 6 Hold ratings, and 0 Sell ratings. The stock is currently trading at $70.11. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict TEM stock could reach $65.00 in the next 12 months. This represents a -7.3% decrease from the current price of $70.11. Please note that this is a projection by Wall Street analysts and not a guarantee.
Tempus AI Inc. generates revenue by providing customized AI platforms that help enterprises enhance operational efficiency and decision-making. By integrating machine learning and predictive analytics, the company offers tools that streamline complex data into actionable insights, serving sectors like healthcare, finance, and logistics.
The highest price target for TEM is $70.00 from David Westenberg at Piper Sandler, which represents a -0.2% decrease from the current price of $70.11.
The lowest price target for TEM is $55.00 from David Westenberg at Piper Sandler, which represents a -21.6% decrease from the current price of $70.11.
The overall analyst consensus for TEM is neutral. Out of 12 Wall Street analysts, 6 rate it as Buy, 6 as Hold, and 0 as Sell, with a median price target of $65.00.
Stock price projections, including those for Tempus AI Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.